MARKET

CDT

CDT

CDT Equity
NASDAQ
7.85
-1.97
-20.06%
After Hours: 8.20 +0.35 +4.46% 19:59 03/27 EDT
OPEN
8.55
PREV CLOSE
9.82
HIGH
11.00
LOW
7.45
VOLUME
106.83K
TURNOVER
--
52 WEEK HIGH
4,200.00
52 WEEK LOW
7.45
MARKET CAP
1.39M
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
1D
CDT Equity Inc trading resumes
TipRanks · 18h ago
CDT Equity Inc trading halted, volatility trading pause
TipRanks · 18h ago
NASDAQ TRADE HALT CONTINUES <CDT.O> VOLATILITY TRADING PAUSE AT 09:30 AM
Reuters · 18h ago
CDT Equity Inc trading halted, news pending
TipRanks · 1d ago
NASDAQ TRADE HALT <CDT.O> HALT NEWS PENDING AT 07:50 PM
Reuters · 1d ago
CDT Equity expands Tapinarof intellectual property portfolio with patent filings
TipRanks · 1d ago
CDT Equity files two tapinarof patent applications; Organon acquisition of Dermavant totals $1.2 billion
Reuters · 1d ago
CDT Equity Submits Two New Patent Applications Over Combination Therapy Pairing Tapinarof With Drugs In Psoriasis, Atopic Dermatitis
Benzinga · 1d ago
More
About CDT
CDT Equity Inc., formerly Conduit Pharmaceuticals, Inc. is a data-driven biotech development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. It applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.

Webull offers CDT Equity Inc stock information, including NASDAQ: CDT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDT stock methods without spending real money on the virtual paper trading platform.